Meridian Bioscience Inc. (VIVO) reported third quarter EPS of $0.19 Thursday morning, which matched the consensus estimate. The company also reaffirmed its full year EPS forecast of $0.72 to $0.75. Meridian Bioscience gapped down sharply Thursday and declined throughout the final 2 hours of trade. The stock finished down by $4.74 at $24.00 on strong volume. The stock dropped below support to close at an 11-month low.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.